Systemic exposure to morphine and the risk of acute chest syndrome in sickle cell disease

Clinical Pharmacology and Therapeutics

Volumn 75, Issue 3, 2004, Pages 140-146

  Kopecky, Ernest A ^b   Jacobson, Sheila ^b   Joshi, Prashant ^b   Koren, Gideon ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

DRUG METABOLITE; MORPHINE; MORPHINE 6 GLUCURONIDE; PLACEBO;

ACUTE CHEST SYNDROME; ADOLESCENT; ANALYTIC METHOD; AREA UNDER THE CURVE; ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEMOGRAPHY; DISEASE ASSOCIATION; DOUBLE BLIND PROCEDURE; DRUG EXPOSURE; DRUG INFUSION; FEMALE; HOSPITALIZATION; HUMAN; MALE; PATIENT; PHYSICIAN; PREVALENCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; SICKLE CELL ANEMIA; SLOW RELEASE FORMULATION; SUSTAINED DRUG RELEASE;

ACUTE DISEASE; ADMINISTRATION, ORAL; ADOLESCENT; ANEMIA, SICKLE CELL; AREA UNDER CURVE; BRONCHIAL DISEASES; CHEST PAIN; CHILD; CHILD, PRESCHOOL; CONSTRICTION, PATHOLOGIC; DOUBLE-BLIND METHOD; DYSPNEA; FEMALE; HUMANS; INFUSIONS, INTRAVENOUS; MALE; MORPHINE; SYNDROME;

EID: 1542346871     PISSN: 00099236     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clpt.2003.10.007     Document Type: Article

References (24)

1. Kaufman R.E. Hydroxyurea specific therapy for sickle cell anemia? J Am Soc Hematol. 79:1992;2503-2506.
2. Lane P.A. Sickle cell disease. Pediatr Clin North Am. 43:1996;639-664.
3. Bunn H.F. Pathogenesis and treatment of sickle cell disease. N Engl J Med. 337:1997;762-769.
4. Alavi J.B. Sickle cell anemia. Med Clin North Am. 68:1984;545-556.
5. Benjamin LJ. Sickle cell disease. In: Max MB, Portenoy RK, Laska EM, editors. Advances in pain research and therapy. New York: Raven Press; 1991. p. 317-31
6. Powars D.R., Weidman J.A., Odom-Maryon T., Niland J.C., Johnson C. Sickle cell chronic lung disease prior morbidity and the risk of pulmonary failure. Medicine. 67:1988;66-76.
7. Golden C., Styles L., Vichinsky E. Acute chest syndrome and sickle cell disease. Curr Opin Hematol. 5:1998;89-92.
8. Vichinsky E. Comprehensive care in sickle cell disease its impact on morbidity and mortality. Semin Hematol. 28:1991;220-226.
9. Platt O.S., Brambilla D.J., Rosse W.F., Milner P.F., Castro O., Steinberg M.H., et al. Mortality in sickle cell disease life expectancy and risk factors for early death. N Engl J Med. 330:1994;1639-1644.
10. Vichinsky E., Styles L. Pulmonary complications. Hematol Oncol Clin North Am. 10:1996;1275-1287.
11. Vichinsky E., Neumayr L.D., Earles A.N., Williams R., Lennette E.T., Dean D., et al. Causes and outcomes of the acute chest syndrome in sickle cell disease. National Acute Chest Syndrome Study Group. [published erratum appears in N Engl J Med 2000;343:824] N Engl J Med. 342:2000;1855-1866.
12. Steingart R. Management of patients with sickle cell disease. Med Clin North Am. 76:1992;669-682.
13. Robieux I.C., Kellner J.D., Coppes M.J., Shaw D., Brown E., Good C., et al. Analgesia in children with sickle cell crisis comparison of intermittent opioids vs. continuous intravenous infusion of morphine and placebo-controlled study of oxygen inhalation. Pediatr Hematol Oncol. 9:1992;317-326.
14. Jacobson S.J., Kopecky E.A., Joshi P., Babul N. Randomised trial of oral for painful episodes of sickle-cell disease in children. Lancet. 350:1997;1358-1361.
15. Twycross R.G. Morphine and diamorphine in the terminally ill patient. Acta Anaesthesiol Scand. 74:(Suppl):1982;128-134.
16. Holford N.H.G., Benet L.Z. Pharmacokinetics and pharmacodynamics: dose selection and the time course of drug action. Katzung B.G. Basic and clinical pharmacology. 7th ed :1998;34-49 Appleton and Lange, Stamford (CT).
17. Lewing K.B., Woods G.M. Sickle cell disease. Rakel R.E. Conn's current therapy. 2000;374-381 W.B. Saunders, Philadelphia.
18. Benz E.J. Hemoglobinopathies. Braunwald E., Fauci A.S., Kasper D.L., Hauser S.L., Longo D.L., Jameson J.L. Harrison's principles of internal medicine. 15th ed :2001;666-674 McGraw-Hill, New York.
19. Pawula M., Barrett D.A., Shaw P.N. An improved extraction method for the HPLC of morphine and its metabolites in plasma. J Pharm Biomed Anal. 11:1993;401-406.
20. McCaffery M, Portenoy RK. Overview of three groups of analgesics. In: McCaffery M, Pasro C, editors. Pain clinical manual. 2nd ed. St Louis: Mosby; 1999. p. 115-28
21. Korpela R., Korvenoja P., Meretoja O. Morphine-sparing effect of acetaminophen in pediatric day-case surgery. Anesthesiology. 91:1999;442-447.
22. Moffat A.C., Kenny G.N., Prentice J.W. Postoperative nefopam and diclofenac. Evaluation of their morphine-sparing effect after upper abdominal surgery. Anaesthesia. 45:1990;302-305.
23. Withington D.E., Patrick J.A., Reynolds F. Histamine release by morphine and diamorphine in man. Anaesthesia. 48:1993;26-29.
24. Enwonwu C.A., Lu M. Elevated plasma histamine in sickle cell anemia. Clin Chim Acta. 203:1991;363-368.